Stanley Anthony J, Hasan Iqbal, Crockett Alan J, van Schayck Onno C P, Zwar Nicholas A
School of Public Health and Community Medicine, University of New South Wales, Kensington, NSW, Australia.
Prim Care Respir J. 2014 Mar;23(1):92-7. doi: 10.4104/pcrj.2014.00015.
The gold standard for the diagnosis of chronic obstructive pulmonary disease (COPD) is spirometry, but there are barriers to its use in primary care.
To externally validate the COPD Diagnostic Questionnaire (CDQ) as a diagnostic tool in patients at increased risk in Australian general practice and to compare its performance with other CDQ validation studies.
Patients were recruited from 36 general practices in Sydney, Australia. Former or current smokers aged 40-85 years with no prior COPD diagnosis were invited to a case-finding appointment with the practice nurse. The CDQ was collected and pre- and postbronchodilator spirometry was performed. Cases for whom complete CDQ data were present and the spirometry met quality standards were analysed.
Of 1,631 patients who attended case-finding recruitment, 1,054 (65%) could be analysed. Spirometry showed 13% had COPD. The ability of the CDQ to discriminate between patients with and without COPD was fair, represented by the area under the receiver operating characteristic curve of 0.713. With a CDQ cut-off point value of 16.5 the sensitivity was 80% and specificity 47% and, at a cut-off point value of 19.5, the sensitivity was 63% and specificity 70%.
The CDQ did not discriminate between patients with and without COPD accurately enough to use as a diagnostic tool in patients at increased risk of COPD in Australian general practice. Further research is needed on the value of the CDQ as a tool for selecting patients for spirometry.
慢性阻塞性肺疾病(COPD)诊断的金标准是肺功能测定,但在基层医疗中应用存在障碍。
在澳大利亚全科医疗中,对慢性阻塞性肺疾病诊断问卷(CDQ)作为诊断工具在高危患者中进行外部验证,并将其性能与其他CDQ验证研究进行比较。
从澳大利亚悉尼的36家全科诊所招募患者。邀请年龄在40 - 85岁、既往无COPD诊断的既往或当前吸烟者到诊所护士处进行病例筛查。收集CDQ,并进行支气管扩张剂使用前和使用后的肺功能测定。对有完整CDQ数据且肺功能测定符合质量标准的病例进行分析。
在1631名参加病例筛查招募的患者中,1054名(65%)可进行分析。肺功能测定显示13%患有COPD。CDQ区分有COPD和无COPD患者的能力一般,受试者工作特征曲线下面积为0.713。CDQ截断点值为16.5时,敏感性为80%,特异性为47%;截断点值为19.5时,敏感性为63%,特异性为70%。
在澳大利亚全科医疗中,对于COPD高危患者,CDQ作为诊断工具,区分有COPD和无COPD患者的准确性不足。需要进一步研究CDQ作为选择肺功能测定患者工具的价值。